Pioneering Soluble Biomarker Discovery
Precise Insights—Advancing Research Through ELISA Assays
The Solubles team at CBmed specializes in the detection and quantification of soluble biomarkers. Our team leverages decades of expertise in biomarker discovery and validation, employing state-of-the-art ELISA assays to provide precise, reproducible data that drives impactful research and innovation.
Soluble biomarkers are key to understanding complex biological processes and disease mechanisms. By focusing on biomarkers found in blood, our team enables researchers to:
• Monitor disease progression and response to therapy.
• Uncover novel diagnostic markers and therapeutic targets.
• Enhance understanding of neurodegenerative, oncological, and immunological conditions.
Our team is specialized at using ELISA (Enzyme-Linked Immunosorbent Assay), a gold standard technique in biomarker research to provide:
• High Sensitivity and Specificity: Detect low-abundance biomarkers with confidence.
• Reliable Quantification: Reproducible results for both exploratory studies and large-scale projects.
The Solubles team provides crucial support for research in:
• Oncology: Discovering soluble markers for cancer diagnostics and monitoring.
• Immunology: Analyzing inflammatory and immune response markers in various conditions.
We believe in a collaborative approach to biomarker research. By partnering with academic institutions, pharmaceutical companies, and clinical research organizations, we provide deep insights into soluble biomarker discovery.